Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Kagami

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Gan No Rinsho. Japan Journal of Cancer Clinics|June 1, 1984
[Afterloading interstitial brachytherapy by Ir-192 seed assembly for malignant brain tumor]M Nishio, T Sakurai, Y Kagami, et al.
British Journal of Cancer|May 30, 2007
A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancerM Ikeda, T Okusaka, Y Ito, et al.
Cancer|April 15, 1997
Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinomaH Ishii, S Okada, K Tokuuye, et al.
Experimental Hematology|January 1, 1993
Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activityT Murate, K Yamashita, H Ohashi, et al.
Leukemia|September 14, 1999
Selective usage of D-type cyclins in lymphoid malignanciesR Suzuki, H Kuroda, H Komatsu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. The IDEC-C2B8 Study GroupK Tobinai, Y Kobayashi, M Narabayashi, et al.
The American Journal of Surgical Pathology|September 1, 1996
Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entityY Yatabe, S Nakamura, M Seto, et al.
International Journal of Hematology|May 10, 2001
Assessment of prognostic factors in follicular lymphoma patientsE Kondo, M Ogura, Y Kagami, et al.
International Journal of Hematology|June 19, 1998
A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34(+)-selection method in cyclin D1(+)-mantle cell lymphomaK Uehira, Y Kagami, M Ogura, et al.
International Journal of Hematology|September 25, 1999
Cytotoxic large T-cell lymphoma with fulminant clinical course, CD8+ and CD56- phenotype, and its relation to Epstein-Barr virus: a report of two casesY Kagami, R Sobue, N Ito, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Gan No Rinsho. Japan Journal of Cancer Clinics|June 1, 1984
[Afterloading interstitial brachytherapy by Ir-192 seed assembly for malignant brain tumor]M Nishio, T Sakurai, Y Kagami, et al.
British Journal of Cancer|May 30, 2007
A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancerM Ikeda, T Okusaka, Y Ito, et al.
Cancer|April 15, 1997
Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinomaH Ishii, S Okada, K Tokuuye, et al.
Experimental Hematology|January 1, 1993
Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activityT Murate, K Yamashita, H Ohashi, et al.
Leukemia|September 14, 1999
Selective usage of D-type cyclins in lymphoid malignanciesR Suzuki, H Kuroda, H Komatsu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. The IDEC-C2B8 Study GroupK Tobinai, Y Kobayashi, M Narabayashi, et al.
The American Journal of Surgical Pathology|September 1, 1996
Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entityY Yatabe, S Nakamura, M Seto, et al.
International Journal of Hematology|May 10, 2001
Assessment of prognostic factors in follicular lymphoma patientsE Kondo, M Ogura, Y Kagami, et al.
International Journal of Hematology|June 19, 1998
A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34(+)-selection method in cyclin D1(+)-mantle cell lymphomaK Uehira, Y Kagami, M Ogura, et al.
International Journal of Hematology|September 25, 1999
Cytotoxic large T-cell lymphoma with fulminant clinical course, CD8+ and CD56- phenotype, and its relation to Epstein-Barr virus: a report of two casesY Kagami, R Sobue, N Ito, et al.
Pageof 12